PI
IPXL

Placemark Investments’s Impax Laboratories, Inc. IPXL Stock Holding History

Placemark Investments’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$209K Buy
+6,654
New +$195K ﹤0.01% 1539
2014
Q3 		– Sell
-7,420
Closed -$220K – 1702
2014
Q2 		$220K Buy
+7,420
New +$200K ﹤0.01% 1524

Other funds holding IPXL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
AG
Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Placemark Investments's IPXL Position: Q4 2014 in Review

Placemark Investments opened a new position in Impax Laboratories, Inc. (IPXL) in Q4 2014: 6,654 shares worth $209K. The stake represents ﹤0.01% of the portfolio and ranks #1539 among its holdings. This is a return to the name: Placemark Investments previously reported a position in IPXL as recently as Q2 2014.

Placemark Investments first reported a position in IPXL in Q2 2014 and has held it in 2 quarters since. The position peaked at $220K in Q2 2014. 178 funds tracked by Wall St. Rank hold IPXL as of Q4 2014.

  • Placemark Investments held 6,654 shares of Impax Laboratories, Inc. worth $209K as of Q4 2014.
  • Impax Laboratories, Inc. was a new Placemark Investments position in Q4 2014.
  • Impax Laboratories, Inc. made up ﹤0.01% of Placemark Investments's portfolio in Q4 2014, its #1539 holding.
  • Placemark Investments first reported a position in Impax Laboratories, Inc. in Q2 2014 and has held it in 2 quarters since.
  • Placemark Investments's Impax Laboratories, Inc. position peaked at $220K in Q2 2014.
  • 178 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.